Cargando…

P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS

Detalles Bibliográficos
Autores principales: Hanes, V., Pan, J., Mytych, D., Chow, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430253/
http://dx.doi.org/10.1097/01.HS9.0000846144.01812.0b
_version_ 1784779710230691840
author Hanes, V.
Pan, J.
Mytych, D.
Chow, V.
author_facet Hanes, V.
Pan, J.
Mytych, D.
Chow, V.
author_sort Hanes, V.
collection PubMed
description
format Online
Article
Text
id pubmed-9430253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94302532022-08-31 P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS Hanes, V. Pan, J. Mytych, D. Chow, V. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430253/ http://dx.doi.org/10.1097/01.HS9.0000846144.01812.0b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hanes, V.
Pan, J.
Mytych, D.
Chow, V.
P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title_full P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title_fullStr P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title_full_unstemmed P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title_short P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS
title_sort p815: pharmacokinetic and pharmacodynamic similarity of abp 959 and eculizumab reference product: unbound eculizumab and ch50 from the randomized, double-blind, single-dose study in healthy volunteers
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430253/
http://dx.doi.org/10.1097/01.HS9.0000846144.01812.0b
work_keys_str_mv AT hanesv p815pharmacokineticandpharmacodynamicsimilarityofabp959andeculizumabreferenceproductunboundeculizumabandch50fromtherandomizeddoubleblindsingledosestudyinhealthyvolunteers
AT panj p815pharmacokineticandpharmacodynamicsimilarityofabp959andeculizumabreferenceproductunboundeculizumabandch50fromtherandomizeddoubleblindsingledosestudyinhealthyvolunteers
AT mytychd p815pharmacokineticandpharmacodynamicsimilarityofabp959andeculizumabreferenceproductunboundeculizumabandch50fromtherandomizeddoubleblindsingledosestudyinhealthyvolunteers
AT chowv p815pharmacokineticandpharmacodynamicsimilarityofabp959andeculizumabreferenceproductunboundeculizumabandch50fromtherandomizeddoubleblindsingledosestudyinhealthyvolunteers